Effect of Yaoshi Xinbao Decoction on Serum Homocysteine and Blood Coagulation Function in Patients with Blood Stasis Syndrome Coronary Heart Disease

LI Dong-yu

doi:10.13422/j.cnki.syfjx.2017120178

您当前的位置：

首页 >

文章列表页 >

Effect of Yaoshi Xinbao Decoction on Serum Homocysteine and Blood Coagulation Function in Patients with Blood Stasis Syndrome Coronary Heart Disease

更新时间：2024-01-04

- Effect of Yaoshi Xinbao Decoction on Serum Homocysteine and Blood Coagulation Function in Patients with Blood Stasis Syndrome Coronary Heart Disease
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 12, Pages: 178-181(2017)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2017120178
  CLC： R285.6
- Published：2017
- 稿件说明：
移动端阅览
LI Dong-yu. Effect of Yaoshi Xinbao Decoction on Serum Homocysteine and Blood Coagulation Function in Patients with Blood Stasis Syndrome Coronary Heart Disease[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(12): 178-181.
DOI：

LI Dong-yu. Effect of Yaoshi Xinbao Decoction on Serum Homocysteine and Blood Coagulation Function in Patients with Blood Stasis Syndrome Coronary Heart Disease[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(12): 178-181. DOI： 10.13422/j.cnki.syfjx.2017120178.

摘要

目的：观察药食心葆汤联合西药治疗冠心病的临床疗效及其对血清同型半胱氨酸（homocysteine，HCY）水平凝血功能的影响，并探讨其作用机制。方法：选取2015年1月至2016年1月于郑州市中医院心内科入院治疗并确诊为心血瘀阻证的冠心病患者200例，按照随机数字表法分为对照组和观察组，对照组102例，观察组98例，对照组患者采用常规西药治疗，观察组在此基础上联合药食心葆汤治疗，药物干预治疗8周，比较两组患者血清同型半胱氨酸（HCY），凝血功能[凝血酶原时间（prothrombin time，PT），部分凝血活酶时间（activated partial thromboplastin time，APTT），纤维蛋白原（fibrinogen，FIB）]等指标。结果：治疗后观察组患者凝血功能、血清HCY水平改善程度优于对照组（P<0.05）；观察组可明显降低CHD患者血清HCY水平（P<0.05），调节患者的凝血功能（P<0.05），组间比较显示两组有明显差别，特别是在改善凝血功能方面，观察组明显优于对照组（P<0.05），对照组治疗前后各项指标没有统计学差异。结论：药食心葆汤联合西药治疗冠心病的临床疗效确切，能有效降低CHD患者HCY水平、调节凝血功能，值得临床推广使用。

Abstract

Objective: To investigate the clinical efficacy of Yaoshi Xinbao decoction combined with western medicine in the treatment of coronary heart disease and observe its effect on serum homocysteine (HCY) level and blood coagulation function. Method: The 200 patients with blood stasis syndrome coronary heart disease from January 2015 to January 2016 in Department of cardiology of our hospital were randomly divided into control group (102 cases) and observation group (98 cases). Patients in control group were treated with conventional western medicine

and patients in observation group received additional Yaoshi Xinbao decoction based on the treatment in control group for 8 weeks. The two groups of patients were compared for serum homocysteine (HCY) and coagulation function (prothrombin time

activated partial thromboplastin time

fibrinogen). Result: The improvement degree of coagulation function and serum HCY level in observation group was better than that in control group after treatment (P<0.05); observation group could significantly reduce the serum HCY level in patients with CHD (P<0.05)

and regulate the blood coagulation function (P<0.05)

with significant differences between the groups

especially in the improvement of coagulation function (P<0.05). Control group had no significant differences before and after treatment. Conclusion: Yaoshi Xinbao decoction combined with western medicine has clear clinical curative effect in treatment of coronary heart disease

which can effectively reduce the level of HCY in CHD patients and regulate blood coagulation function

so it is worthy of clinical promotion.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics

Establishment and Evaluation of Rat Model of Acute Myocardial Infarction in Coronary Heart Disease with Qi and Yin Deficiency Syndrome Based on Sleep Deprivation Combined with Coronary Artery Ligation

Mechanism of Xuefu Zhuyutang in Intervening in Ferroptosis in Rats with Coronary Heart Disease with Blood Stasis Syndrome Based on ACSL4 Signalling Pathway

Construction of an Intelligent Diagnosis and Treatment Ontology for Traditional Chinese Medicine Based on Clinical Practice Guidelines：A Case Study of Coronary Heart Disease

Effect of Yiqi Huoxue Prescription on cAMP/Epac1/Rap1 Signaling Pathway in Coronary Heart Disease Rats with Qi Deficiency and Blood Stasis Syndrome

Related Author

HU Longxiao

GAO Jiabei

MA Weihao

LU Jieming

GAO Yunxiao

YUAN Yue

ZHANG Qiuyan

CHEN Xiaoxiao

Related Institution

Natural History Museum of China

Beijing Key Laboratory of Chinese Materia Pharmacology，National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases，Institute of Basic Medical Sciences， Xiyuan Hospital，China Academy of Chinese Medical Sciences

School of Clinical Medicine，Beijing University of Chinese Medicine

Institute of Basic Medical Sciences，Xiyuan Hospital，China Academy of Chinese Medical Sciences

Hunan Traditional Chinese Medical College

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰